Chemoinformaics analysis of GALANGIN-3-METHYL-ETHER
| Molecular Weight | 284.267 | nRot | 2 |
| Heavy Atom Molecular Weight | 272.171 | nRig | 18 |
| Exact Molecular Weight | 284.068 | nRing | 3 |
| Solubility: LogS | -3.497 | nHRing | 1 |
| Solubility: LogP | 3.239 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 33 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 21 | No. of Aromatic Carbocycles | 2 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 16 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 17 |
| nHA | 5 | APOL | 38.7315 |
| nHD | 2 | BPOL | 16.3785 |
| QED | 0.756 |
| Synth | 2.181 |
| Natural Product Likeliness | 1.337 |
| NR-PPAR-gamma | 0.952 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.262 |
| Pgp-sub | 0.008 |
| HIA | 0.006 |
| CACO-2 | -4.851 |
| MDCK | 0.0000144 |
| BBB | 0.024 |
| PPB | 0.966199 |
| VDSS | 0.605 |
| FU | 0.0436836 |
| CYP1A2-inh | 0.978 |
| CYP1A2-sub | 0.731 |
| CYP2c19-inh | 0.743 |
| CYP2c19-sub | 0.064 |
| CYP2c9-inh | 0.799 |
| CYP2c9-sub | 0.922 |
| CYP2d6-inh | 0.817 |
| CYP2d6-sub | 0.376 |
| CYP3a4-inh | 0.658 |
| CYP3a4-sub | 0.122 |
| CL | 4.681 |
| T12 | 0.851 |
| hERG | 0.019 |
| Ames | 0.663 |
| ROA | 0.145 |
| SkinSen | 0.636 |
| Carcinogencity | 0.15 |
| EI | 0.923 |
| Respiratory | 0.24 |
| NR-Aromatase | 0.89 |
| Antiviral | Yes |
| Prediction | 0.777567 |